Makasasa, Muamara S.
HRN: 21-28-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
CEFUROXIME 1.5GM (VIAL)
12/03/2022
12/10/2022
IVT
1.5GMS
NOW THEN Q8
REPEAT LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes